Cite

HARVARD Citation

    Sraieb, M. et al. (2020). Assessing the quality of life of patients with metastatic castration-resistant prostate cancer with bone metastases receiving [223Ra]RaCl2 therapy. Medicine. 99 (38), p. . [Online]. 
  
Back to record